Kumlesh Kumar Dev
Overview
Explore the profile of Kumlesh Kumar Dev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mekhaeil M, Conroy M, Dev K
J Neuroimmune Pharmacol
. 2023 Nov;
18(4):592-609.
PMID: 37924373
Metachromatic leukodystrophy (MLD) is a severe demyelinating, autosomal recessive genetic leukodystrophy, with no curative treatment. The disease is underpinned by mutations in the arylsulfatase A gene (ARSA), resulting in deficient...
2.
Mekhaeil M, Conroy M, Dev K
Neurotherapeutics
. 2023 Jul;
20(5):1347-1368.
PMID: 37525026
Metachromatic leukodystrophy (MLD) is a severe demyelinating, autosomal recessive genetic leukodystrophy. The disease is underpinned by mutations in the arylsulfatase A gene (ARSA), resulting in deficient activity of the arylsulfatase...
3.
Mekhaeil M, Dev K, Conroy M
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158955
Over the past decade, Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors have arisen as a novel and promising targeted therapy for breast cancer gene (BRCA)-mutated ovarian and breast cancer patients. Therapies targeting...
4.
Mattes H, Dev K, Bouhelal R, Barske C, Gasparini F, Guerini D, et al.
ChemMedChem
. 2010 Sep;
5(10):1693-6.
PMID: 20815011
No abstract available.